Good afternoon :)
Switch to
Place Order

Aurobindo Pharma Ltd

AUROPHARMA
Health CarePharmaceuticals
LargecapWith a market cap of ₹53,806 cr, stock is ranked 86
Low RiskStock is 1.95x as volatile as Nifty
916.901.40 (-0.15%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
LargecapWith a market cap of ₹53,806 cr, stock is ranked 86
Low RiskStock is 1.95x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
10.09
PB RatioPB Ratio
3.20
Dividend YieldDiv. Yield
0.44%
Sector PESector PE
40.14
Sector PBSector PB
5.78
Sector Div YldSctr Div Yld
0.62%

Forecast & RatingsDetailed Forecast 

89%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Aurobindo Pharma Limited is a pharmaceutical company. The Company is engaged in producing oral and injectable generic formulations and active pharmaceutical ingredients (APIs).

Investor PresentationView older 

May 31, 2021

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

201820192020202116.5719.7223.2927.972.422.362.835.33
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Certificate under SEBI (Depositories and Participants) Regulations, 2018 
Announced OnJul 9, 2021

Aurobindo Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 | Download

Aurobindo Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 | Download

Updates 
Announced OnJul 1, 2021

Aurobindo Pharma Limited has informed the Exchange regarding '1) The Board of Directors of the Company at its meeting held today i.e. July 1, 2021, has approved the transfer of business undertaking comprised in Unit-4, on a going concern basis, to Eugia Pharma Specialities Limited, a wholly owned subsidiary of the Company.2) Further to our intimation on February 27, 2021, with regard to transfer of business undertaking comprised in Unit-10, on a going concern basis, to APL Healthcare Limited, a wholly owned subsidiary of the Company, by way of slump sale through a Business Transfer Agreement, the Board of Directors of the Company at its meeting held today i.e. July 1, 2021 has fixed the consideration at Rs. 1,315 crores after consideration of closing date adjustments. '. | Download

Aurobindo Pharma Limited has informed the Exchange regarding '1) The Board of Directors of the Company at its meeting held today i.e. July 1, 2021, has approved the transfer of business undertaking comprised in Unit-4, on a going concern basis, to Eugia Pharma Specialities Limited, a wholly owned subsidiary of the Company.2) Further to our intimation on February 27, 2021, with regard to transfer of business undertaking comprised in Unit-10, on a going concern basis, to APL Healthcare Limited, a wholly owned subsidiary of the Company, by way of slump sale through a Business Transfer Agreement, the Board of Directors of the Company at its meeting held today i.e. July 1, 2021 has fixed the consideration at Rs. 1,315 crores after consideration of closing date adjustments. '. | Download

Cash Dividend 
Ex. DateFeb 22, 2021

Interim 3 • Div/Share: ₹ 1.5

See all events